142 related articles for article (PubMed ID: 34556297)
1. Autocrine and paracrine effects of a novel podocyte gene, RARRES1.
Chen A; Lee K; He JC
Kidney Int; 2021 Oct; 100(4):745-747. PubMed ID: 34556297
[TBL] [Abstract][Full Text] [Related]
2. Disparate roles of retinoid acid signaling molecules in kidney disease.
Chen A; Liu Y; Lu Y; Lee K; He JC
Am J Physiol Renal Physiol; 2021 May; 320(5):F683-F692. PubMed ID: 33645319
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury.
Feng Y; Sun Z; Fu J; Zhong F; Zhang W; Wei C; Chen A; Liu BC; He JC; Lee K
Kidney Int; 2024 Apr; ():. PubMed ID: 38697478
[TBL] [Abstract][Full Text] [Related]
4. Astragalus polysaccharide alleviates angiotensin II-induced glomerular podocyte dysfunction by inhibiting the expression of RARRES1 and LCN2.
Peng L; Zhang C; Xiao G
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):504-515. PubMed ID: 36876579
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor responder1 promotes development of glomerular diseases via the Nuclear Factor-κB signaling pathway.
Möller-Hackbarth K; Dabaghie D; Charrin E; Zambrano S; Genové G; Li X; Wernerson A; Lal M; Patrakka J
Kidney Int; 2021 Oct; 100(4):809-823. PubMed ID: 34147551
[TBL] [Abstract][Full Text] [Related]
6. The yin and yang of retinoic acid signaling in kidney diseases.
Wei Q; Dong Z
J Clin Invest; 2020 Oct; 130(10):5124-5126. PubMed ID: 32925167
[TBL] [Abstract][Full Text] [Related]
7. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.
Sison K; Eremina V; Baelde H; Min W; Hirashima M; Fantus IG; Quaggin SE
J Am Soc Nephrol; 2010 Oct; 21(10):1691-701. PubMed ID: 20688931
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.
Huebner H; Strick R; Wachter DL; Kehl S; Strissel PL; Schneider-Stock R; Hartner A; Rascher W; Horn LC; Beckmann MW; Ruebner M; Fahlbusch FB
J Exp Clin Cancer Res; 2017 Nov; 36(1):165. PubMed ID: 29169400
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation.
Lassen E; Daehn IS
Kidney Int; 2022 Apr; 101(4):673-676. PubMed ID: 35314050
[TBL] [Abstract][Full Text] [Related]
11. Response of Renal Podocytes to Excessive Hydrostatic Pressure: a Pathophysiologic Cascade in a Malignant Hypertension Model.
Abu Hamad R; Berman S; Hachmo Y; Stark M; Hasan F; Doenyas-Barak K; Efrati S
Kidney Blood Press Res; 2017; 42(6):1104-1118. PubMed ID: 29224013
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
13. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
14. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I
Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
[TBL] [Abstract][Full Text] [Related]
15. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.
Müller-Deile J; Worthmann K; Saleem M; Tossidou I; Haller H; Schiffer M
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1656-67. PubMed ID: 19828679
[TBL] [Abstract][Full Text] [Related]
16. Inducible ATF3-NFAT axis aggravates podocyte injury.
Zhang H; Liang S; Du Y; Li R; He C; Wang W; Liu S; Ye Z; Liang X; Shi W; Zhang B
J Mol Med (Berl); 2018 Jan; 96(1):53-64. PubMed ID: 29038896
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury.
't Hart D; Li J; van der Vlag J; Nijenhuis T
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830371
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
19. IP
Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
[TBL] [Abstract][Full Text] [Related]
20. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
